Analysis of N-linked glycan alterations in tissue and serum reveals promising biomarkers for intrahepatic Cholangiocarcinoma.
Cancer research communications. . NIHMSID: NIHMS1876078.
Spatial Omics Reveals that Cancer-Associated Glycan Changes Occur Early in Liver Disease Development in a Western Diet Mouse Model of MASLD.
Journal of proteome research. . NIHMSID: NIHMS2093305.
Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript.
J Virol.
1994 Dec;68(12):7816-24. doi: 10.1128/JVI.68.12.7816-7824.1994. PubMed PMID:
7966571; PubMed Central PMCID:
PMC237243.
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice.
Virology.
1995 Jan 10;206(1):633-40. doi: 10.1016/s0042-6822(95)80080-8. PubMed PMID:
7831818.
Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
Virology.
1995 Nov 10;213(2):660-5. doi: 10.1006/viro.1995.0038. PubMed PMID:
7491790.
A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics.
J Neurovirol.
1996 Aug;2(4):268-78. doi: 10.3109/13550289609146890. PubMed PMID:
8799218.
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
Virology.
1996 Nov 1;225(1):72-81. doi: 10.1006/viro.1996.0576. PubMed PMID:
8918535.
Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion.
Proc Natl Acad Sci U S A.
1997 Mar 4;94(5):1822-7. doi: 10.1073/pnas.94.5.1822. PubMed PMID:
9050863; PubMed Central PMCID:
PMC20001.
Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited.
Proc Natl Acad Sci U S A.
1997 Mar 18;94(6):2380-5. doi: 10.1073/pnas.94.6.2380. PubMed PMID:
9122203; PubMed Central PMCID:
PMC20096.
A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins.
Biochem Soc Trans.
1997 Nov;25(4):1188-93. doi: 10.1042/bst0251188. Review. PubMed PMID:
9449973.
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.
Nat Med.
1998 May;4(5):610-4. doi: 10.1038/nm0598-610. PubMed PMID:
9585237.
Alpha-glucosidase inhibitors as potential broad based anti-viral agents.
FEBS Lett.
1998 Jun 23;430(1-2):17-22. doi: 10.1016/s0014-5793(98)00525-0. Review. PubMed PMID:
9678587.
The role of N-linked glycosylation in the secretion of hepatitis B virus.
Adv Exp Med Biol.
1998;435:195-205. doi: 10.1007/978-1-4615-5383-0_19. PubMed PMID:
9498078.
Role of glycan processing in hepatitis B virus envelope protein trafficking.
Adv Exp Med Biol.
1998;435:207-16. doi: 10.1007/978-1-4615-5383-0_20. Review. PubMed PMID:
9498079.
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
Proc Natl Acad Sci U S A.
1999 Oct 12;96(21):11878-82. doi: 10.1073/pnas.96.21.11878. PubMed PMID:
10518544; PubMed Central PMCID:
PMC18380.
Glycoproteins: rapid sequencing technology for N-linked and GPI anchor glycans.
Biotechnol Genet Eng Rev.
1999;16:1-21. doi: 10.1080/02648725.1999.10647969. Review. PubMed PMID:
10819075.
The HSV 1 genome in quiescently infected NGF differentiated PC12 cells can not be stimulated by HSV superinfection.
J Neurovirol.
2000 Aug;6(4):341-9. doi: 10.3109/13550280009030760. PubMed PMID:
10951558.
Synovial stimulatory protein fragments copurify with woodchuck hepatitis virus: implications for the etiology of arthritis in chronic hepatitis B virus infection.
Arthritis Rheum.
2001 Feb;44(2):486-7. doi: 10.1002/1529-0131(200102)44:2<486::AID-ANR69>3.0.CO;2-P. PubMed PMID:
11229482.
Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
Hepatology.
2001 Jun;33(6):1488-95. doi: 10.1053/jhep.2001.25103. PubMed PMID:
11391538.
Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
J Virol.
2001 Oct;75(19):8987-98. doi: 10.1128/JVI.75.19.8987-8998.2001. PubMed PMID:
11533162; PubMed Central PMCID:
PMC114467.
A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma.
Dis Markers.
2001;17(3):179-89. doi: 10.1155/2001/963023. Review. PubMed PMID:
11790885; PubMed Central PMCID:
PMC3851119.
Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Virology.
2002 Mar 30;295(1):10-9. doi: 10.1006/viro.2002.1370. PubMed PMID:
12033761.
The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
Antiviral Res.
2002 Sep;55(3):425-35. doi: 10.1016/s0166-3542(02)00075-x. PubMed PMID:
12206880.
Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ.
Antivir Chem Chemother.
2002 Sep;13(5):299-304. doi: 10.1177/095632020201300505. PubMed PMID:
12630678.
Structure-activity relationship of a new class of anti-hepatitis B virus agents.
Antimicrob Agents Chemother.
2002 Dec;46(12):4004-8. doi: 10.1128/AAC.46.12.4004-4008.2002. PubMed PMID:
12435712; PubMed Central PMCID:
PMC132742.
Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells.
J Virol.
2003 May;77(9):5503-6. doi: 10.1128/jvi.77.9.5503-5506.2003. PubMed PMID:
12692252; PubMed Central PMCID:
PMC153946.
Molecular viral oncology of hepatocellular carcinoma.
Oncogene.
2003 Aug 11;22(33):5093-107. doi: 10.1038/sj.onc.1206557. Review. PubMed PMID:
12910247.
The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.
J Virol.
2003 Nov;77(22):11933-40. doi: 10.1128/jvi.77.22.11933-11940.2003. PubMed PMID:
14581530; PubMed Central PMCID:
PMC254279.
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status.
Proteomics.
2004 Mar;4(3):826-38. doi: 10.1002/pmic.200300625. PubMed PMID:
14997503.
alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses.
Antimicrob Agents Chemother.
2004 Jun;48(6):2085-90. doi: 10.1128/AAC.48.6.2085-2090.2004. PubMed PMID:
15155204; PubMed Central PMCID:
PMC415597.
Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker.
J Virol Methods.
2005 Mar;124(1-2):167-72. doi: 10.1016/j.jviromet.2004.11.019. Epub 2004 Dec 23. PubMed PMID:
15664065.
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
Proc Natl Acad Sci U S A.
2005 Jan 18;102(3):779-84. doi: 10.1073/pnas.0408928102. Epub 2005 Jan 10. PubMed PMID:
15642945; PubMed Central PMCID:
PMC545516.
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
J Hepatol.
2005 Dec;43(6):1007-12. doi: 10.1016/j.jhep.2005.05.028. Epub 2005 Jun 28. PubMed PMID:
16137783.
Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.
J Virol.
2005 Oct;79(20):12914-20. doi: 10.1128/JVI.79.20.12914-12920.2005. PubMed PMID:
16188993; PubMed Central PMCID:
PMC1235823.
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
J Proteome Res.
2006 Feb;5(2):308-15. doi: 10.1021/pr050328x. PubMed PMID:
16457596.
Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity?.
DNA Cell Biol.
2006 Mar;25(3):165-70. doi: 10.1089/dna.2006.25.165. Review. PubMed PMID:
16569195.
Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays.
Antiviral Res.
2006 Nov;72(2):116-24. doi: 10.1016/j.antiviral.2006.05.006. Epub 2006 Jun 2. PubMed PMID:
16780964.
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers.
Mol Cell Proteomics.
2006 Oct;5(10):1957-67. doi: 10.1074/mcp.M600176-MCP200. Epub 2006 Jun 7. Review. PubMed PMID:
16760258.
alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
Antivir Chem Chemother.
2006;17(5):259-67. doi: 10.1177/095632020601700503. PubMed PMID:
17176630.
The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: development of a novel therapeutic vaccine candidate.
Virology.
2007 Aug 15;365(1):10-9. doi: 10.1016/j.virol.2007.03.042. Epub 2007 Apr 25. PubMed PMID:
17462693.
The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome.
Virology.
2007 Dec 5;369(1):69-77. doi: 10.1016/j.virol.2007.06.048. Epub 2007 Aug 23. PubMed PMID:
17716702; PubMed Central PMCID:
PMC4422056.
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.
Antimicrob Agents Chemother.
2007 Dec;51(12):4427-37. doi: 10.1128/AAC.00541-07. Epub 2007 Sep 17. PubMed PMID:
17875990; PubMed Central PMCID:
PMC2167973.
Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.
J Virol.
2008 Feb;82(3):1259-70. doi: 10.1128/JVI.01600-07. Epub 2007 Nov 28. PubMed PMID:
18045939; PubMed Central PMCID:
PMC2224448.
Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus.
Antivir Chem Chemother.
2007;18(1):49-59. doi: 10.1177/095632020701800105. PubMed PMID:
17354651.
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
Gastroenterology.
2008 Jul;135(1):226-33. doi: 10.1053/j.gastro.2008.03.022. Epub 2008 Mar 29. PubMed PMID:
18457674; PubMed Central PMCID:
PMC2644903.
N-linked glycosylation of the liver cancer biomarker GP73.
J Cell Biochem.
2008 May 1;104(1):136-49. doi: 10.1002/jcb.21610. PubMed PMID:
18004786; PubMed Central PMCID:
PMC4620713.
Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I.
Virology.
2009 Feb 5;384(1):12-5. doi: 10.1016/j.virol.2008.11.027. Epub 2008 Dec 16. PubMed PMID:
19091367; PubMed Central PMCID:
PMC2765373.
Fucosylated glycoproteins as markers of liver disease.
Dis Markers.
2008;25(4-5):259-65. doi: 10.1155/2008/264594. Review. PubMed PMID:
19126969; PubMed Central PMCID:
PMC3827789.
Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.
J Proteome Res.
2009 Feb;8(2):595-602. doi: 10.1021/pr800752c. PubMed PMID:
19099421; PubMed Central PMCID:
PMC4427194.
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
J Proteome Res.
2009 Feb;8(2):620-30. doi: 10.1021/pr8007545. PubMed PMID:
19128049; PubMed Central PMCID:
PMC2651839.
What would you like to do?